Rolimus (5mg, 10mg)

CIPLA LTD.

ROLIMUS contains Drug / Molecule called “Everilomus”. Everolimus, an immunosuppressive drug, is prescribed for the management of graft rejection in graft versus host disease (GVHD) in organ transplanted patients. It belongs to a class of medications called as protein kinase inhibitor. Everolimus is a potent inhibitor of the growth and proliferation of tumour cells, has shown to reduce glycolysis.

Category:

Indication

Rolimus is an immuno-suppressant which is used in kidney, liver, and heart transplant patients.

Note

Precaution

  • Rolimus is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated in patients with clinical history of melanoma, clotting disorders, hepatic diseases.

Related products